SPRY partners with Luna to advance the next generation of in-home rehabilitation
Read More
Menu
Billable Codes
Exclusion Rules
Common Comorbidities
Associated CPT® Codes
Key Facts
Multiple sclerosis ICD 10 code G35 classifies one of the most common demyelinating diseases affecting the nervous system. This condition primarily affects young adults, typically beginning between ages 20 and 40, and shows higher prevalence in women than men. A recent study involving 1,091 children and adolescents with MS found that 72.2% were female, with diagnosis occurring at an average age of 15.7 years.
The ICD-10 code for multiple sclerosis (G35) falls under diseases of the nervous system classification. Understanding this specific code is essential for accurate medical billing and proper documentation. Multiple sclerosis is characterized by the destruction of myelin in the central nervous system, leading to weakness, numbness, coordination problems, and vision disturbances. Although there is no cure for multiple sclerosis, available treatments may slow disease progression and help manage symptoms.
As of FY2026 (effective October 1, 2025), CMS restructured code G35 into a non-billable header code with four new subtype-specific codes, so it's crucial to understand the nuances of G35 and its documentation requirements. Proper coding not only ensures accurate reimbursement but also supports appropriate patient care through precise diagnosis classification. This guide explores the essential aspects of multiple sclerosis coding, from clinical features to the FY2026 restructuring that impacts your medical billing practices.
G35 designates multiple sclerosis, a complex neurological condition affecting the central nervous system, and is classified as a chronic condition requiring ongoing medical attention. G35 was billable on its own through September 30, 2025 (FY2025). Effective October 1, 2025 (FY2026), CMS restructured G35 into a non-billable header code, so claims must now use one of its new subtype-specific codes instead (see below).
Code G35 encompasses several variants of multiple sclerosis, creating a comprehensive classification for this demyelinating disorder. The inclusion terms specifically cover:
G35 serves as the sole dedicated code for multiple sclerosis, unlike other neurological conditions that may have multiple subcodes. This simplifies documentation while still acknowledging the various presentations of the disease. Furthermore, G35 represents an autoimmune disorder primarily affecting young adults, characterized by the destruction of myelin in the central nervous system.
Within the ICD-10 hierarchical structure, G35 falls under Chapter VI: Diseases of the Nervous System (G00-G99). More specifically, it belongs to the block G35-G37, which covers demyelinating diseases of the central nervous system. This classification block includes three distinct categories:
This placement within the coding hierarchy reflects the pathophysiological nature of multiple sclerosis as a demyelinating condition. Additionally, for Diagnostic Related Group (DRG) classification purposes, G35 maps to MS-DRGs 058-060, depending on the presence of complications or comorbidities.
The official descriptor for G35 is simply "Multiple sclerosis". Nevertheless, the World Health Organization and Centers for Medicare & Medicaid Services provide additional clarification through inclusion terms that expand upon this primary descriptor.
The code lacks exclusion notes, which means no conditions must be coded elsewhere when using G35. This straightforward coding approach simplifies documentation requirements while maintaining clinical specificity. Through FY2025, the ICD-10-CM descriptors for G35 remained unchanged from previous versions; this changed with the FY2026 restructuring described below.
For clinical classification purposes, G35 is categorized under the Clinical Classification Software Refined (CCSR) category NVS005, designated as the default assignment for both inpatient and outpatient principal diagnoses.
Understanding the clinical features of multiple sclerosis is crucial for accurate ICD-10 code G35 assignment. Multiple sclerosis represents an autoimmune disorder primarily affecting young adults, characterized by destruction of myelin in the central nervous system.
Inflammation of optic nerves (optic neuritis) is typically the first symptom of multiple sclerosis. This early manifestation often resolves within one to two weeks, causing many patients to forgo medical attention. Consequently, this crucial diagnostic indicator may be overlooked. Symptoms of optic neuritis include:
For coding purposes, documenting these early manifestations supports medical necessity and helps establish the timeline of disease progression, essential for proper G35 application.
During multiple sclerosis, the immune system (specifically white blood cells and T cells) attacks the insulating layer of nerve fibers (myelin sheath), resulting in demyelination of axons. This immune-mediated process causes inflammation primarily in the white matter of the central nervous system. As a result, nerve conduction—the transmission of information to and from the brain—becomes significantly compromised.
Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. These lesions form the basis for diagnosis through the principle of "lesions disseminated in space and time," meaning MS plaques occur in multiple parts of the CNS over time.
Clinical manifestations documented for G35 coding include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. Moreover, fatigue (persistent exhaustion) and worsening of symptoms with temperature increases (Uhthoff's phenomenon) are characteristic findings.
The disease pattern typically presents as recurrent attacks followed by partial recovery (relapsing-remitting MS), though acute fulminating and chronic progressive forms also occur. Indeed, after approximately 15-20 years, about half of people initially diagnosed with relapsing MS transition to secondary progressive MS, characterized by gradual worsening between attacks.
ICD-10-CM code G35 remained stable with no structural changes from 2016 through FY2025 (effective through September 30, 2025). Effective October 1, 2025 (FY2026), however, CMS restructured G35 into a non-billable header code, replacing direct billing on G35 with four new subtype-specific codes: G35.A (Relapsing-remitting multiple sclerosis), G35.B (Primary progressive multiple sclerosis, further specified as G35.B0 unspecified, G35.B1 active, or G35.B2 non-active), G35.C (Secondary progressive multiple sclerosis, similarly specified as G35.C0, G35.C1, or G35.C2), and G35.D (Multiple sclerosis, unspecified). Medical billing professionals must now select the most clinically specific subtype code for reimbursement rather than billing G35 directly.
No inclusions or exclusions were added to the G35 code through FY2025; it continued to maintain its long-standing applicable terms, including disseminated multiple sclerosis, generalized multiple sclerosis, multiple sclerosis NOS, multiple sclerosis of brain stem, and multiple sclerosis of cord. (CMS had also announced 50 new ICD-10-PCS procedure codes effective April 1, 2025, with no new ICD-10-CM diagnosis codes introduced in that mid-year update.) The FY2026 restructuring described above is the first structural change to G35 since its 2016 introduction.
The April 2025 mid-year diagnosis code update addressed revisions and typographical errors rather than substantive changes to the G35 code, and the basic descriptor remained "Multiple sclerosis" through FY2025. The Type 2 Excludes notes continue to apply across the G00-G99 chapter, directing coders to use separate codes for conditions like infectious diseases, neoplasms, and pregnancy complications when they occur alongside multiple sclerosis. As noted above, the October 1, 2025 (FY2026) update did substantively restructure G35 into a non-billable header with four new subtype codes.
G35 exists within a structured relationship with codes G36 (Other acute disseminated demyelination) and G37 (Other demyelinating diseases of central nervous system):
Through FY2025, G35 mapped to MS-DRG codes 058-060 (Multiple sclerosis and cerebellar ataxia) for DRG grouping purposes, with the specific assignment depending on whether major complications or comorbidities exist. Coders should confirm current DRG grouper logic for the new G35.A–G35.D subtype codes under FY2026.
Proper coding practices for multiple sclerosis using ICD-10 code G35 directly impact reimbursement outcomes and claims processing. Medical billers must understand several critical aspects of G35 usage to avoid denials and ensure appropriate payment.
Through FY2025, for inpatient stays G35 mapped to three possible MS-DRG groupings under version 42.0, effective April 1, 2025:
The assigned DRG directly affects reimbursement levels, with higher payments for cases involving complications. Documentation must clearly establish any complications to support appropriate DRG assignment and prevent revenue loss.
G35 is absolutely acceptable as a first-listed or primary diagnosis code. Despite this, confusion exists among some payers and electronic lookup systems. Certain sources incorrectly indicate that G35 requires an F02 or F48 code listed first.
Surprisingly, some insurance companies, such as Ambetter in Indiana, have erroneously denied claims with G35 as the primary diagnosis. Upon provider follow-up, Ambetter acknowledged these denials were mistakes and agreed to reprocess the claims correctly. If you encounter similar denials, promptly contact the payer for claim resubmission.
Several documentation and coding pitfalls occur when billing for multiple sclerosis:
Such errors potentially lead to three significant consequences: inappropriate treatment decisions, increased audit risk, and potential reimbursement loss due to insufficient supporting documentation.
Since October 1, 2015, all claims must use ICD-10-CM codes like G35 rather than the previous ICD-9-CM code 340. This cutoff date remains important for historical claims processing and compliance reviews.
What are the key takeaways for medical billers handling MS cases?
Understanding ICD-10 code G35 remains essential for medical billing professionals dealing with multiple sclerosis patients. Throughout this guide, you have learned that G35 was a stable, billable code with no significant structural changes from 2016 through September 30, 2025. Effective October 1, 2025 (FY2026), however, CMS restructured G35 into a non-billable header code with four new subtype-specific codes (G35.A–G35.D), so claims must now use the appropriate subtype code rather than G35 directly. This code family still encompasses several variants of multiple sclerosis, including relapsing-remitting, primary progressive, secondary progressive, and unspecified presentations.
Medical billers should be aware that although G35 is absolutely acceptable as a primary diagnosis, some payers have erroneously denied such claims. Therefore, staying vigilant about incorrect denials and promptly addressing them prevents revenue loss. The consistent classification of multiple sclerosis under the demyelinating diseases block (G35-G37) also helps clarify its relationship with other similar neurological conditions.
Last but certainly not least, maintaining thorough documentation of disease progression, treatment plans, and functional status not only supports proper coding but also reduces audit risk. As you navigate the current medical billing landscape, this comprehensive understanding of G35 will undoubtedly strengthen your coding accuracy and reimbursement success for multiple sclerosis cases.
The ICD-10 code for multiple sclerosis is G35. This code is used to classify and identify multiple sclerosis in medical billing and documentation.
Through FY2025, G35 was billable and could be used to specify a diagnosis on reimbursement claims. Effective October 1, 2025 (FY2026), G35 became a non-billable header code — claims must now use one of its new subtype codes (G35.A, G35.B, G35.C, or G35.D) instead.
G35 remained unchanged from 2016 through FY2025. Effective October 1, 2025 (FY2026), CMS restructured it into a non-billable header code with four new subtype-specific codes: G35.A (relapsing-remitting), G35.B (primary progressive), G35.C (secondary progressive), and G35.D (unspecified).
Yes, G35 can be used as a primary or first-listed diagnosis code. However, some insurance companies have erroneously denied claims with G35 as the primary diagnosis, so it's important to be aware of this potential issue and address it promptly if it occurs.
Through FY2025, G35 mapped to three possible MS-DRG groupings: 058 (with major complication or comorbidity), 059 (with complication or comorbidity), and 060 (without CC/MCC), depending on the presence of complications or comorbidities. Coders should confirm current DRG grouper logic for the new G35.A–G35.D subtype codes under FY2026.
.avif)
.webp)
